Second-line treatment of metastatic gastric cancer: Current options and future directions-Reference-Cited by-同舟云学术

Second-line treatment of metastatic gastric cancer: Current options and future directions

Published:2015 Issue:41 Volume:21 Page:11621
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Kanagavel Dheepak

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference118 articles.

1. Correa P, Chen VW. Gastric cancer. Cancer Surv 1994;19-20:55-76.

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Stomach Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. Available from: http://globocan.iarc.fr/old/FactSheets/cancers/stomach-new.asp.

4. Gastric Cancer: Preoperative chemotherapy of locally advanced gastric cancer

5. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on Second-Line Therapy with Ramucirumab for Metastatic Gastric Cancer: A Two-Center Study on Romanian Population;Life;2023-12-05

2. Optimizing the Continuum of Care in Gastric Cancer;OncoTargets and Therapy;2023-11

3. Integrative analysis of cancer-associated fibroblast signature in gastric cancer;Heliyon;2023-09

4. Neutrophil extracellular traps−related signature predicts the prognosis and immune infiltration in gastric cancer;Frontiers in Medicine;2023-08-10

5. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer;Journal of Cancer Research and Clinical Oncology;2023-01-06